glp-1 obesity drug news today Popular medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds Current Strategies in Managing Obesity
Description
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes
P.VelazquezE
Given these pathophysiological changes, there has been growing interest in the potential therapeutic effects of GLP-1 RAs on MFI, inflammation, and muscle fiber characteristics [77, 82]
Finally, it is worth mentioning that flatulence may occasionally appear, although studies reporting its frequency are lacking
[DOI] [PubMed] [Google Scholar] 48.White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F
Kidney International
